- Home
- INMB vs AGRZ Comparison
INMB vs AGRZ Comparison
Compare INMB & AGRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- AGRZ
- Stock Information
- Founded
- INMB 2015
- AGRZ 2020
- Country
- INMB United States
- AGRZ Malaysia
- Employees
- INMB N/A
- AGRZ N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- AGRZ Farming/Seeds/Milling
- Sector
- INMB Health Care
- AGRZ Consumer Staples
- Exchange
- INMB Nasdaq
- AGRZ Nasdaq
- Market Cap
- INMB 55.0M
- AGRZ 56.6M
- IPO Year
- INMB 2019
- AGRZ 2025
- Fundamental
- Price
- INMB $1.98
- AGRZ $4.05
- Analyst Decision
- INMB Buy
- AGRZ
- Analyst Count
- INMB 4
- AGRZ 0
- Target Price
- INMB $9.53
- AGRZ N/A
- AVG Volume (30 Days)
- INMB 564.4K
- AGRZ 553.1K
- Earning Date
- INMB 10-30-2025
- AGRZ 01-01-0001
- Dividend Yield
- INMB N/A
- AGRZ N/A
- EPS Growth
- INMB N/A
- AGRZ N/A
- EPS
- INMB N/A
- AGRZ 0.04
- Revenue
- INMB $50,000.00
- AGRZ $9,138,479.00
- Revenue This Year
- INMB $142.83
- AGRZ N/A
- Revenue Next Year
- INMB $14,780.90
- AGRZ N/A
- P/E Ratio
- INMB N/A
- AGRZ $77.40
- Revenue Growth
- INMB N/A
- AGRZ 121.21
- 52 Week Low
- INMB $1.71
- AGRZ $2.52
- 52 Week High
- INMB $11.64
- AGRZ $5.13
- Technical
- Relative Strength Index (RSI)
- INMB 41.99
- AGRZ N/A
- Support Level
- INMB $1.92
- AGRZ N/A
- Resistance Level
- INMB $2.16
- AGRZ N/A
- Average True Range (ATR)
- INMB 0.11
- AGRZ 0.00
- MACD
- INMB 0.03
- AGRZ 0.00
- Stochastic Oscillator
- INMB 42.86
- AGRZ 0.00
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.